Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
| Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
|---|---|---|---|---|---|---|---|---|---|---|
| Vindesine sulfate | Compound-112531 | Approved | Eli Lilly And Company | Eldisine | United Kingdom | Small Cell Lung Carcinoma; Breast Neoplasms; Esophageal Neoplasms; Lung Neoplasms; Carcinoma, Non-Small-Cell Lung; Leukemia; Lymphoma; Melanoma | Eli Lilly And Company | 1979-01-01 | Leukemia; Esophageal Neoplasms; Small Cell Lung Carcinoma; Breast Neoplasms; Lung Neoplasms; Lymphoma; Carcinoma, Non-Small-Cell Lung; Melanoma | Details |
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| BB-1701 | BB-1701 | Phase 2 Clinical | Bliss Biopharmaceutical (Hangzhou) Co Ltd | Solid tumours; Stomach Neoplasms; Carcinoma, Transitional Cell; Breast Neoplasms; Metastatic breast cancer; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.
A-Z
